相似文献
1
Association of SNPs in CDKN2A (P14ARF) Tumour Suppressor Gene With Endometrial Cancer in Postmenopausal Women.
In Vivo. 2020 Mar-Apr;34(2):943-951. doi: 10.21873/invivo.11862.
2
Impact of and Polymorphisms on Endometrial Cancer Risk and Onset.
In Vivo. 2019 May-Jun;33(3):917-924. doi: 10.21873/invivo.11559.
3
p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
Cancer. 2011 Mar 15;117(6):1227-35. doi: 10.1002/cncr.25605. Epub 2010 Nov 8.
4
Polymorphisms of codon 72 of the TP53 gene in endometrial carcinoma of postmenopausal women.
Postepy Hig Med Dosw (Online). 2013 Dec 16;67:1312-8. doi: 10.5604/17322693.1080804.
5
135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.
Pol J Pathol. 2011 Sep;62(3):157-62.
6
HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):213-9. doi: 10.1158/1055-9965.epi-03-0241.
7
Significant association of genetic polymorphism of human nonmetastatic clone 23 type 1 gene with an increased risk of endometrial cancer.
Gynecol Oncol. 2010 Oct;119(1):70-5. doi: 10.1016/j.ygyno.2010.06.013.
8
The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations.
Int J Gynecol Cancer. 2010 Aug;20(6):993-9. doi: 10.1111/IGC.0b013e3181e76a4d.
9
An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Cancer Detect Prev. 2007;31(2):102-9. doi: 10.1016/j.cdp.2007.01.001. Epub 2007 Apr 6.
10
Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
Cancer. 2008 Apr 15;112(8):1699-707. doi: 10.1002/cncr.23335.
引用本文的文献
1
3'UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma.
In Vivo. 2021 May-Jun;35(3):1529-1536. doi: 10.21873/invivo.12406.
本文引用的文献
1
Impact of and Polymorphisms on Endometrial Cancer Risk and Onset.
In Vivo. 2019 May-Jun;33(3):917-924. doi: 10.21873/invivo.11559.
2
Aberrant Expression of p14 in Human Cancers: A New Biomarker?
Tumor Microenviron. 2018 Apr-Jun;1(2):37-44. doi: 10.4103/tme.tme_24_17. Epub 2019 Feb 4.
3
Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.
J Cell Physiol. 2018 Nov;233(11):8952-8961. doi: 10.1002/jcp.26830. Epub 2018 Jun 15.
4
Regulatory Network of ARF in Cancer Development.
Mol Cells. 2018 May 31;41(5):381-389. doi: 10.14348/molcells.2018.0100. Epub 2018 Apr 18.
5
Association of the independent polymorphisms in CDKN2A with susceptibility of acute lymphoblastic leukemia.
Biosci Rep. 2018 Jun 27;38(3). doi: 10.1042/BSR20180331. Print 2018 Jun 29.
6
Immunohistochemical reaction of the glandular epithelium in endometrial hyperplasia compared to endometrial carcinoma.
Rom J Morphol Embryol. 2017;58(3):791-800.
7
Triple negative endometrial cancer.
Ginekol Pol. 2017;88(4):212-214. doi: 10.5603/GP.a2017.0040.
8
The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinoma.
Oncotarget. 2017 Apr 11;8(15):25334-25344. doi: 10.18632/oncotarget.15835.
9
Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells.
Cell Physiol Biochem. 2016;40(6):1367-1376. doi: 10.1159/000453189. Epub 2016 Dec 19.
10
Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.
Oncotarget. 2016 Nov 8;7(45):73045-73054. doi: 10.18632/oncotarget.12196.
Zotero 插件